Literature DB >> 5441544

Warfarin metabolism in man: identification of metabolites in urine.

R J Lewis, W F Trager.   

Abstract

After administration of the coumarin anticoagulant racemic warfarin to normal humans, seven fluorescent compounds were chromatographically separated from extracts of their urine. Four of these were identified using mass spectrometry, thin-layer chromatography, and ultraviolet absorption spectroscopy. One metabolic pathway, reduction of the acetonyl side chain of warfarin, resulted in the formation of a second asymmetric carbon atom, and two diastereoisomer alcohols were identified. These warfarin alcohols are structurally similar to pharmacologically active coumarin derivatives. They have not been reported in animal studies. In addition, 6- and 7-hydroxywarfarin were identified. These are the first studies to document the metabolic fate of warfarin in the normal human.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5441544      PMCID: PMC535763          DOI: 10.1172/JCI106310

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  11 in total

1.  HEREDITARY TRANSMISSION OF EXCEPTIONAL RESISTANCE TO COUMARIN ANTICOAGULANT DRUGS. THE FIRST REPORTED KINDRED.

Authors:  R A O'REILLY; P M AGGELER; M S HOAG; L S LEONG; M L KROPATKIN
Journal:  N Engl J Med       Date:  1964-10-15       Impact factor: 91.245

2.  Metabolism of coumarin in man.

Authors:  W H Shilling; R F Crampton; R C Longland
Journal:  Nature       Date:  1969-02-15       Impact factor: 49.962

3.  Genetic control of dicumarol levels in man.

Authors:  E S Vesell; J G Page
Journal:  J Clin Invest       Date:  1968-12       Impact factor: 14.808

4.  The metabolism of 4-C14-warfarin sodium by the rat.

Authors:  W M Barker; M A Hermodson; K P Link
Journal:  J Pharmacol Exp Ther       Date:  1970-02       Impact factor: 4.030

5.  Warfarin resistance in the rat.

Authors:  J G Pool; R A O'Reilly; L J Schneiderman; M Alexander
Journal:  Am J Physiol       Date:  1968-09

6.  Studies on the role of the intestinal microflora in the metabolism of coumarin in rats.

Authors:  R R Scheline
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1968

7.  Warfarin resistance.

Authors:  R J Lewis; M Spivack; T H Spaet
Journal:  Am J Med       Date:  1967-04       Impact factor: 4.965

8.  The metabolism of coumarin-2-14C and 7-hydroxycoumarin-2-14C (umbelliferone-2-14C) in the rat.

Authors:  C F Van Sumere; H Teuchy
Journal:  Arch Int Physiol Biochim       Date:  1968-12

9.  Toxicity tests on suspected warfarin resistant house mice (Mus musculus L.).

Authors:  F P Rowe; R Redfern
Journal:  J Hyg (Lond)       Date:  1965-09

10.  The biotransformation of ethyl biscoumacetate (tromexan) in man, rabbit and dog.

Authors:  J J BURNS; M WEINER; G SIMSON; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1953-05       Impact factor: 4.030

View more
  20 in total

Review 1.  Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.

Authors:  Mike Ufer
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 2.  Protein binding of coumarin anticoagulants in disease states.

Authors:  K Bachmann; R Shapiro
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

Review 3.  Drug interactions with warfarin.

Authors:  M J Serlin; A M Breckenridge
Journal:  Drugs       Date:  1983-06       Impact factor: 9.546

4.  Pharmacokinetic and pharmacodynamic interactions between phenprocoumon and atenolol or metoprolol.

Authors:  H Spahn; W Kirch; E Mutschler; E E Ohnhaus; N R Kitteringham; H J Lögering; D Paar
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

5.  Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.

Authors:  R J Lewis; W F Trager; K K Chan; A Breckenridge; M Orme; M Roland; W Schary
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

6.  Biotransformation and pharmacokinetics of acenocoumarol (Sintrom) in man.

Authors:  W Dieterle; J W Faigle; C Montigel; M Sulc; W Theobald
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

Review 7.  Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.

Authors:  D E Drayer
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

8.  A cellular system for quantitation of vitamin K cycle activity: structure-activity effects on vitamin K antagonism by warfarin metabolites.

Authors:  Jamil A Haque; Matthew G McDonald; John D Kulman; Allan E Rettie
Journal:  Blood       Date:  2013-12-02       Impact factor: 22.113

Review 9.  Pharmacogenetics of oral anticoagulants: a basis for dose individualization.

Authors:  Simone Stehle; Julia Kirchheiner; Andreas Lazar; Uwe Fuhr
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

10.  Microbial transformations of warfarin: stereoselective reduction by Nocardia corallina and Arthrobacter species.

Authors:  P J Davis; J D Rizzo
Journal:  Appl Environ Microbiol       Date:  1982-04       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.